Furthermore, a combination of survival rates, clinico-pathological features, and Cox regression analyses revealed that chromatin assembly factor 1, subunit B (CHAF1B) was a novel diagnostic and prognostic signature biomarker in HCC patients. This evidence concerns the gene CHAF1B and hepatocellular carcinoma.